← Leaderboards
Mikael Pittet
Massachusetts General Hospital
$14,206,093
Attributed
$19,023,809
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2008–23$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,023,809 · 12
By mechanism
R01$9,795,744 · 4
T32$3,276,108 · 1
P01$2,215,120 · 2
U01$1,761,342 · 1
P50$1,210,505 · 2
R21$398,318 · 1
Top collaborators
- Ralph Weissleder11 shared
- Allon Moshe Klein5 shared
- Rakesh K. Jain1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Rakesh K. Jain$48,476,214
- Dai Fukumura$13,639,390
- Matthias Nahrendorf$28,669,447
- Filip K Swirski$20,484,870
- Lance L Munn$15,934,149
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsResponseImageTumorIn VivoMediatingMalignant NeoplasmsBasePathway InteractionsMacrophageImmuneT-LymphocytePharmaceutical PreparationsBehaviorMouse ModelResolutionPlaySiteImmunotherapyImmunityImmune SystemNeoplastic CellImmunotherapeutic AgentPhenotype
Grant awards (46)
TRAINING GRANT IN MOLECUCLAR IMAGING RESEARCH AND CANCER SYSTEMS ANALYSIS$624,208
T32 · FY2023 · CA
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy$365,650
P01 · FY2023 · CA · contact PI
TRAINING GRANT IN MOLECUCLAR IMAGING RESEARCH AND CANCER SYSTEMS ANALYSIS$541,273
T32 · FY2022 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy$521,401
R01 · FY2022 · CA
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy$455,328
P01 · FY2022 · CA · contact PI
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy$537,668
R01 · FY2021 · CA
TRAINING GRANT IN MOLECUCLAR IMAGING RESEARCH AND CANCER SYSTEMS ANALYSIS$521,885
T32 · FY2021 · CA
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy$464,943
P01 · FY2021 · CA · contact PI
Imaging tumor associated macrophage (TAM) function$380,871
R01 · FY2021 · CA
Training Grant in Molecular Imaging Research$578,185
T32 · FY2020 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy$542,592
R01 · FY2020 · CA
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy$465,265
P01 · FY2020 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$409,360
R01 · FY2020 · AI · contact PI
Imaging tumor associated macrophage (TAM) function$380,871
R01 · FY2020 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy$531,772
R01 · FY2019 · CA
Training Grant in Molecular Imaging Research$530,960
T32 · FY2019 · CA
Project 3: Myeloid-lymphoid cell crosstalk in HNSCC therapy$463,934
P01 · FY2019 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$409,360
R01 · FY2019 · AI · contact PI
Imaging tumor associated macrophage (TAM) function$369,444
R01 · FY2019 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy$570,518
R01 · FY2018 · CA
Training Grant in Molecular Imaging Research$479,597
T32 · FY2018 · CA
In vivo behavior of monocytes in resting and inflammatory conditions$409,360
R01 · FY2018 · AI · contact PI
Imaging tumor associated macrophage (TAM) function$381,239
R01 · FY2018 · CA
In vivo behavior of monocytes in resting and inflammatory conditions$166,860
R01 · FY2018 · AI · contact PI
Reprogramming PDAC tumor microenvironment to improve immunotherapy$1,761,342
U01 · FY2017 · CA
In vivo behavior of monocytes in resting and inflammatory conditions$410,007
R01 · FY2017 · AI · contact PI
Imaging tumor associated macrophage (TAM) function$381,606
R01 · FY2017 · CA
In vivo behavior of monocytes in resting and inflammatory conditions$71,321
R01 · FY2017 · AI · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$410,648
R01 · FY2016 · AI · contact PI
Imaging endogenously produced tumor derived micro vesicles$180,061
R21 · FY2016 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$434,203
R01 · FY2015 · AI · contact PI
Imaging endogenously produced tumor derived micro vesicles$218,257
R21 · FY2015 · CA · contact PI
Imaging Immune Cell Modulation in Cancer Therapy$107,687
P50 · FY2015 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$434,203
R01 · FY2014 · AI · contact PI
Imaging Immune Cell Modulation in Cancer Therapy$109,751
P50 · FY2014 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$408,151
R01 · FY2013 · AI · contact PI
Imaging Immune Cell Modulation in Cancer Therapy$115,084
P50 · FY2013 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$434,470
R01 · FY2012 · AI · contact PI
Imaging Immune Cell Modulation in Cancer Therapy$110,183
P50 · FY2012 · CA · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$434,671
R01 · FY2011 · AI · contact PI
In vivo behavior of monocytes in resting and inflammatory conditions$366,672
R56 · FY2010 · AI · contact PI
Imaging CD8 Immunity in Cancer$294,160
P50 · FY2010 · CA · contact PI
Imaging CD8 Immunity in Cancer$297,044
P50 · FY2009 · CA · contact PI
Imaging CD8 Immunity in Cancer$176,596
P50 · FY2008 · CA · contact PI
Imaging of progenitor cells in tumor environments$382,544
R01 · FY2004 · CA
Imaging of progenitor cells in tumor environments$382,604
R01 · FY2003 · CA